Seed Stage BioTech Co backed by Peter Thiel
This week we’re sharing our first BioTech deal. This company has developed a cheap and reversible gene therapy for both humans and pets. Sam Altman (Y Combinator) led the company’s pre-seed and they’re currently raising a seed round with participation from investors like Peter Thiel (PayPal, Palantir), Rob Rhinehart (Soylent), and Ryan Peterson (Flexport).
The low cost and scalability of this kind of treatment has the potential to address diseases like cardiovascular disease, muscle wasting, bone loss, inflammation, and more.
There’s limited capacity but if you’re interested in learning more, respond to this email and Zack will be in touch with the pitch deck and other materials.